MotsCles : Pipette ; Oncologie ; International (Equipe internationale) ; Gros plan ; Gants de protections ; Gant de protection ; Echantillon ; Détail ; Chercheur, Chercheurs (Recherche) ; Cancérologie ; ; Signalisation normale et pathologique : de l'embryon aux thérapies innovantes des cancers - Institut Curie / CNRS UMR 3347 / Inserm U1021 ; Recherche en laboratoire ; Recherche ; Orsay ; Laboratoire ; Horizontal ; Gant violet ; Gants violets ; Equipe Signalisation, développement et tumeurs cérébrales ; Centre de Recherche ; Blouse de protection ; Blouses de protection ; Blouse blanche
Joint research institutions
Institut Curie laboratories are joint-employer laboratories between CNRS and/or INSERM and/or Pierre & Marie Curie University (a founding member of Sorbonne University) and/or Paris-Descartes University and/or Versailles Saint Quentin University and/or Paris-Sud University, which are both founding members of Paris Saclay University, and/or Mines ParisTech or INRIA.
Founding and Board Member
Institut Curie is a founding member of Paris Sciences et Lettres - PSL Research University. PSL brings together some of France's most prestigious and internationally respected academic and research institutions in a broad range of disciplines.
Institut Curie is a founding member of Pierre-Gilles de Gennes Institute – IPGG – which gathers experts in microfluidics from various disciplines and develop both fundamental and applied research.
Institut Curie is a founding member of the UNICANCER Group that brings together French Comprehensive Cancer Centers, promotes their cancer research organisation and pools resources and competencies to give a new dynamic to patient care.
Institut Curie is a board member of the SATT Lutech. SATT Lutech isa private technology transfer company designed to facilitate the transfer of early stage innovations from the lab to successful products and services with the real potential to improve life quality, transform industries, and create tremendous social & economic value. This is done by investing in the development of convincing proof of concept and of prototypes.
Institut Curie is a board member of the Institut Carnot network. To create a true and integrated network dynamic and take full advantage of their joint commitment in favour of partnership research and innovation, the Carnot institutes are members (through their home institution) of a uniting structure.
Institut Curie is a board member of the Cancéropôle Ile-de-France, a public interest group whose primary mission is to pool cancer research in the Paris region. Cancéropôle IdF manages a network ofinstitutions specializing in Cancer research and care in the Paris region allowing innovative projects to be developed.
Institut Curie has framework agreements with key partners designed to create a dynamic network of collaboration :
- Assistance Publique Hôpitaux de Paris - Ambroise Paré Hospital : digestive and soft tissus oncology
- Institut Mutualiste Montsouris: thoracic, uro- and hemato-oncology
- Foch Hospital: thoracic, uro- and gynecological oncology
In 2016, Institut Curie and Institut Pasteur signed an ambitious scientific partnership agreement to strengthen scientific collaboration between the two institutes, pool their resources and intensify their training activities.